SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 12,714.84 |
| Enterprise Value ($M) | 22,355.13 |
| Book Value ($M) | 9,585.10 |
| Book Value / Share | 21.55 |
| Price / Book | 1.33 |
| NCAV ($M) | -4,541.82 |
| NCAV / Share | -10.21 |
| Price / NCAV | -2.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.01 |
| Return on Equity (ROE) | 0.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 13.51 |
| Current Ratio | 13.51 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,728.61 |
| Assets | 15,855.52 |
| Liabilities | 6,270.43 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | General Atlantic Llc | 5.60 | 0.00 | |
| 13G/A | Morgan Stanley | 9.90 | -21.85 | |
| 13G/A | Adage Capital Partners Gp, L.l.c. | 1.59 | -71.82 | |
| 13G/A | Fmr Llc | 10.00 | 99.78 | |
| 13G/A | Vanguard Group Inc | 8.08 | 20.22 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 91,725 | 1,028,014 | 8.92 | |
| 273,182 | 1,763,843 | 15.49 | |
| 383,445 | 2,393,563 | 16.02 | |
| 194,356 | 1,585,593 | 12.26 | |
| 316,365 | 2,484,973 | 12.73 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| RNXT – RenovoRx Inc | ROIV – Roivant Sciences Ltd |
| RPHM – Reneo Pharmaceuticals Inc | RPTX – Repare Therapeutics Inc |
| RTVA – Artiva Biotherapeutics Inc |
Financial data and stock pages provided by
Fintel.io